Sunesis Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report
- Pages: 44
- Published: November 2020
- Report Code: ML2712515SA
Sunesis Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Sunesis Pharmaceuticals, Inc (Sunesis or 'the company') develops and commercializes oncology therapeutics for the treatment of hematologic and solid cancers. The company's major products include Vosaroxin, TAK-580, SSN-510 and Vecabrutinib. The company has collaboration agreement with Biogen Idec MA, Inc. to discover, develop and commercialize small molecule inhibitors of the human protein Raf kinase and with Takeda Pharmaceutical Company Limited to develop and commercialize preclinical inhibitors of PDK1 and TAK-580. Sunesis conducts various clinical trials and analysis for developing products that identifies and implements alternative methods for treating cancer and also obtain licenses for developing various critical products. The company is headquartered in South San Francisco, California, the US.
Scope
– Detailed information on Sunesis Pharmaceuticals, Inc. required for business and competitor intelligence needs
– A study of the major internal and external factors affecting Sunesis Pharmaceuticals, Inc. in the form of a SWOT analysis
– An in-depth view of the business model of Sunesis Pharmaceuticals, Inc. including a breakdown and examination of key business segments
– Intelligence on Sunesis Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
– News about Sunesis Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
– Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
- Gain understanding of Sunesis Pharmaceuticals, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Sunesis Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Sunesis Pharmaceuticals, Inc.'s business structure, strategy and prospects.
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.